rs144019351

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002968.3(SALL1):​c.2178G>A​(p.Arg726Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,614,176 control chromosomes in the GnomAD database, including 232 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 22 hom., cov: 32)
Exomes 𝑓: 0.014 ( 210 hom. )

Consequence

SALL1
NM_002968.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0880

Publications

4 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 16-51140044-C-T is Benign according to our data. Variant chr16-51140044-C-T is described in ClinVar as Benign. ClinVar VariationId is 258862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.088 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0112 (1712/152290) while in subpopulation AMR AF = 0.015 (229/15292). AF 95% confidence interval is 0.0139. There are 22 homozygotes in GnomAd4. There are 789 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1712 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002968.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL1
NM_002968.3
MANE Select
c.2178G>Ap.Arg726Arg
synonymous
Exon 2 of 3NP_002959.2
SALL1
NM_001127892.2
c.1887G>Ap.Arg629Arg
synonymous
Exon 2 of 3NP_001121364.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL1
ENST00000251020.9
TSL:1 MANE Select
c.2178G>Ap.Arg726Arg
synonymous
Exon 2 of 3ENSP00000251020.4
SALL1
ENST00000566102.1
TSL:1
c.77-2492G>A
intron
N/AENSP00000455582.1
SALL1
ENST00000440970.6
TSL:5
c.2178G>Ap.Arg726Arg
synonymous
Exon 3 of 4ENSP00000407914.2

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1705
AN:
152172
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00273
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.0518
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0126
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0146
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0140
AC:
3511
AN:
251492
AF XY:
0.0134
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.0210
Gnomad ASJ exome
AF:
0.0480
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0131
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.0158
GnomAD4 exome
AF:
0.0136
AC:
19809
AN:
1461886
Hom.:
210
Cov.:
53
AF XY:
0.0133
AC XY:
9690
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00260
AC:
87
AN:
33480
American (AMR)
AF:
0.0204
AC:
914
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0471
AC:
1232
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00380
AC:
328
AN:
86258
European-Finnish (FIN)
AF:
0.0136
AC:
725
AN:
53420
Middle Eastern (MID)
AF:
0.0309
AC:
178
AN:
5768
European-Non Finnish (NFE)
AF:
0.0139
AC:
15423
AN:
1112004
Other (OTH)
AF:
0.0152
AC:
921
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1325
2651
3976
5302
6627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0112
AC:
1712
AN:
152290
Hom.:
22
Cov.:
32
AF XY:
0.0106
AC XY:
789
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00277
AC:
115
AN:
41568
American (AMR)
AF:
0.0150
AC:
229
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0518
AC:
180
AN:
3472
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4824
European-Finnish (FIN)
AF:
0.0126
AC:
134
AN:
10622
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0146
AC:
994
AN:
68010
Other (OTH)
AF:
0.0170
AC:
36
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
91
182
273
364
455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0169
Hom.:
11
Bravo
AF:
0.0125
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 10, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Townes syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
4.8
DANN
Benign
0.53
PhyloP100
0.088
Mutation Taster
=74/26
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144019351; hg19: chr16-51173955; API